RGOS
Russell Sust Global Opportunities Complex ETF
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ Holdings
๐ฐ Distributions
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
N/A
Annual Growth
5 years average annual growth
๐ฐ
4.38%
Annual distribution yield
Based on the most recent distribution
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
0
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
RGOS.AX was created on 2024-04-12 by Russell. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to outperform the Funds benchmark, before costs and tax, over the long term by providing exposure to a diversified portfolio of predominantly international shares.
๐ Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ Top Holdings
Show moreTop holdings information is not yet available for this fund. For more information please visit the fund manager's website.
๐ฐ Distributions
Payouts
๐ฐ Annual Distribution Yield*
4.38%
๐ฐ Annual Distribution Earnings Per $1,000 invested**
$43.80
๐ฐ Most Recent Distribution Franked Percentage Estimate
0.20%
๐ฐ Average Distribution Franked Percentage Estimate
0.11 %
๐ฐ Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Estimate your distribution
If you held
$
of RGOS, your last distribution payment(s) would have been:
$ 14.88
on Mon Oct 14 2024
$ 411.75
on Mon Jul 15 2024
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2024
$0.88
0.10%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
2015
$0.00
0.00%
๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$21.34
๐ฐ Price To Earnings Ratio
0.00
๐ฐ Price To Book Ratio
0.00
๐ฐ Leveraged
No
๐ฐ Inverse
No
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in RGOS
0
๐ Total Capital Earnings
N/A
๐ Average investment frequency
N/A
๐ต Average investment amount
N/A
โฐ Last time a customer invested in RGOS
N/A
RGOS investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in RGOS also invest in...
Want more shares? Try these...
Argent Biopharma Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-12-21. Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The firm is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.
๐ Performance (5Yr p.a)
127.06%
๐ Share price
$0.25 AUD
๐ฆ LOGISTICS
Ramsay Health Care Ltd. engages in the healthcare services and the operation of hospitals and day surgery facilities. The company is headquartered in Sydney, New South Wales and currently employs 89,000 full-time employees. The Companyโs segments include Asia Pacific, UK, France and Nordics. Its businesses include Ramsay Australia, Ramsay Sante, Ramsay UK, and Elysium Healthcare. Ramsay Australia has over 73 private hospitals and day surgery units in Australia. Ramsay Sante is a private care provider in Europe and operates 443 multidisciplinary hospitals and clinics and 130 primary care centers across five countries. Ramsay UK has a network of 34 acute hospitals and day procedure centers in England providing a comprehensive range of clinical specialties to private and self-insured patients. Elysium Healthcare is an independent sector provider of specialist health and care services. Its four core service streams are mental health, neurological, learning disabilities and children and education.
๐ Performance (5Yr p.a)
-9.22%
๐ Share price
$39.05 AUD
๐๏ธ SOCIALLY AWARE
๐ฉบ HEALTH CARE
๐ HIGH ESG SCORE
๐ณ ENVIRONMENTAL
Riversgold Ltd. engages in the exploration and development of mineral resources. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2017-10-10. The firm is focused on discovering and developing large lithium systems in the Pilbara and Yilgarn cratons of Western Australia. Its projects include Pilbara Lithium Projects, Southern Cross-Marvel Loch Lithium Project, Kurnalpi Region Projects, and South Australian Projects. The Pilbara Lithium Projects include Tambourah Project, Wodgina East and Upper Five Mile Creek. The Kurnalpi Project comprises 10 exploration licenses and one application. The company is located between 50 kilometers (km) and 120 km east to south-east of the regional mining center town of Kalgoorlie-Boulder in the Eastern Goldfields of Western Australia. The South Australian Projects include the Churchill Dam Iron-Oxide Copper-Gold Project, which is in the Gawler Craton, approximately 20 km west of Woomera and 90 km southwest of the giant Olympic Dam deposit in South Australia. The Upper Five Mile Creek Project is located over 20 km south-east of Nullagine.
๐ Performance (5Yr p.a)
-14.00%
๐ Share price
$0.00 AUD
โ๏ธ MINING
RGN
Region Group engages in the business of investing in and managing shopping centres. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-11-26. The firm is engaged in investing in a geographically diverse portfolio of convenience-based retail centers located across Australia. Its portfolio focuses on the non-discretionary retail sector (primarily convenience retailers and grocery outlets) and is anchored by long-term leases to tenants. The firm owns and manages approximately 92 convenience-based retail properties. The Companyโs properties include Albury, Annandale Central, Auburn Central, AYR (Burdekin Plaza), Bakewell, Belmont Central, Bentons Square, Blakes Crossing, Brookwater Village, Burnie Plaza, Bushland Beach, Busselton, Cabarita, Cardiff, Central Highlands (Emerald), Chancellor Park Marketplace, Claremont Plaza, Cooloola Cove, Currambine Central, Delacombe Town Centre, Drayton Central, and Bentons Square, among others.
๐ Performance (5Yr p.a)
-3.96%
๐ Share price
$2.15 AUD
๐ REAL ESTATE
๐ณ ENVIRONMENTAL